These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8179443)

  • 1. Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service.
    Kershaw B; White RH; Mungall D; Van Houten J; Brettfeld S
    Arch Intern Med; 1994 May; 154(9):1005-11. PubMed ID: 8179443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate use of heparin. Empiric vs nomogram-based dosing.
    Gunnarsson PS; Sawyer WT; Montague D; Williams ML; Dupuis RE; Caiola SM
    Arch Intern Med; 1995 Mar; 155(5):526-32. PubMed ID: 7864708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation.
    Shalansky KF; FitzGerald JM; Sunderji R; Traboulay SJ; O'Malley B; McCarron BI; Naiman S
    Pharmacotherapy; 1996; 16(6):1076-84. PubMed ID: 8947981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The successful application of a heparin nomogram in a community hospital.
    Hollingsworth JA; Rowe BH; Brisebois FJ; Thompson PR; Fabris LM
    Arch Intern Med; 1995 Oct; 155(19):2095-100. PubMed ID: 7575069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with heparin dosing at Christchurch Hospital.
    Ward ML; Duffull SB
    N Z Med J; 1998 Jun; 111(1068):228-30. PubMed ID: 9695751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
    Myzienski AE; Lutz MF; Smythe MA
    Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
    Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N
    Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic heparin monitoring service in a small community hospital.
    Pawloski SJ; Kersh PL
    Hosp Pharm; 1992 Aug; 27(8):703-6, 723. PubMed ID: 10119735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy-managed, weight-based heparin protocol.
    Rivey MP; Peterson JP
    Am J Hosp Pharm; 1993 Feb; 50(2):279-84. PubMed ID: 8480784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin dosage adjustment in patients with deep-vein thrombosis using heparin concentrations rather than activated partial thromboplastin time.
    Groce JB; Gal P; Douglas JB; Steuterman MC
    Clin Pharm; 1987 Mar; 6(3):216-22. PubMed ID: 3665377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
    Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
    Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A standard heparin nomogram for the management of heparin therapy.
    Cruickshank MK; Levine MN; Hirsh J; Roberts R; Siguenza M
    Arch Intern Med; 1991 Feb; 151(2):333-7. PubMed ID: 1789820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an intravenous heparin nomogram in a coronary care unit.
    Paradiso-Hardy FL; Cheung B; Geerts WH
    Can J Cardiol; 1996 Sep; 12(9):802-8. PubMed ID: 8842133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements.
    White RH; Zhou H; Woo L; Mungall D
    Arch Intern Med; 1997 Nov; 157(21):2468-72. PubMed ID: 9385298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center.
    Balcezak TJ; Krumholz HM; Getnick GS; Vaccarino V; Lin ZQ; Cadman EC
    Am J Manag Care; 2000 Mar; 6(3):329-38. PubMed ID: 10977433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.
    Anand S; Ginsberg JS; Kearon C; Gent M; Hirsh J
    Arch Intern Med; 1996 Aug 12-26; 156(15):1677-81. PubMed ID: 8694666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
    Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol.
    Saya FG; Coleman LT; Martinoff JT
    Am J Hosp Pharm; 1985 Sep; 42(9):1965-9. PubMed ID: 4050813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.